PT - JOURNAL ARTICLE AU - Algis Džiugys AU - Martynas Bieliūnas AU - Gediminas Skarbalius AU - Edagaras Misiulis AU - Robertas Navakas TI - Simplified model of Covid-19 epidemic prognosis under quarantine and estimation of quarantine effectiveness AID - 10.1101/2020.04.28.20083428 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.28.20083428 4099 - http://medrxiv.org/content/early/2020/06/17/2020.04.28.20083428.short 4100 - http://medrxiv.org/content/early/2020/06/17/2020.04.28.20083428.full AB - A simplified model of Covid-19 epidemic dynamics under quarantine conditions and method to estimate quarantine effectiveness are developed. The model is based on the growth rate of new infections when total number of infections is significantly smaller than population size of infected country or region. The model is developed on the basis of collected epidemiological data of Covid19 pandemic, which shows that the growth rate of new infections has tendency to decrease linearly when the quarantine is imposed in a country (or a region) until it reaches a constant value, which corresponds to the effectiveness of quarantine measures taken in the country. The growth rate of new infections can be used as criteria to estimate quarantine effectiveness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is funded by the Research Council of Lithuania under the project P-MIP-17-108 "ComDetect" (Agreement No. S-MIP-17-69), 2017-2020.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB and/or ethics committee approvals were neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are available from the corresponding author upon request. Data for the infected cases count from various countries is obtained from the data collected in [2,17]. Dates of the imposed quarantine were collected from [16]. https://en.wikipedia.org/wiki/Template:2020_coronavirus_quarantines_outside_Hubei https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases